Mold Relief Formula
NDC 59623-013, Kali Muriaticum, Gelsemium, Kali Bichromicum, Sabadilla, Histaminum, Mold Mix., liquid, from Integrative Healing Institute, LLC.
- Product NDC
- 59623-013
- Status
- Listed
- Labeler
- Integrative Healing Institute, LLC
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59623-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM CHLORIDE6 [hp_X]/mL
- GELSEMIUM SEMPERVIRENS ROOT12 [hp_C]/mL
- POTASSIUM DICHROMATE12 [hp_C]/mL
- SCHOENOCAULON OFFICINALE SEED12 [hp_C]/mL
- HISTAMINE DIHYDROCHLORIDE30 [hp_C]/mL
- ALTERNARIA ALTERNATA12 [hp_X]/mL
- ASPERGILLUS FUMIGATUS12 [hp_X]/mL
- ASPERGILLUS NIGER VAR. NIGER12 [hp_X]/mL
- BOLETUS SATANAS FRUITING BODY12 [hp_X]/mL
- BOTRYTIS CINEREA12 [hp_X]/mL
- CANDIDA ALBICANS12 [hp_X]/mL
- PASSALORA FULVA12 [hp_X]/mL
- FUSARIUM OXYSPORUM12 [hp_X]/mL
- COCHLIOBOLUS SATIVUS12 [hp_X]/mL
- RHIZOPUS STOLONIFER12 [hp_X]/mL
- AUREOBASIDIUM PULLULANS VAR. PULLUTANS12 [hp_X]/mL
- USTILAGO MAYDIS12 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59623-013-01 | 59623001301 | 30 mL in 1 BOTTLE, DROPPER (59623-013-01) |
| 59623-013-02 | 59623001302 | 59 mL in 1 BOTTLE, DROPPER (59623-013-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 59623-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59623-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59623-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.